Recorded Chinese product: 英卡膦酸二钠片英卡膦酸二钠片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 丽珠集团丽珠制药厂Chinese legal name: 丽珠集团丽珠制药厂
主要成分Active Ingredients
- 英卡膦酸二钠一水合物Yingka Linsuan Erna Yishui Hewu
药物知识说明
英卡膦酸二钠一水合物是一种在国家药监局注册认定的药品。标注生产企业为丽珠集团丽珠制药厂。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：丽珠集团丽珠制药厂Chinese legal name: 丽珠集团丽珠制药厂、丽珠集团丽珠制药厂Chinese legal name: 丽珠集团丽珠制药厂、丽珠集团丽珠制药厂Chinese legal name: 丽珠集团丽珠制药厂。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 英卡膦酸二钠片) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 丽珠集团丽珠制药厂.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 丽珠集团丽珠制药厂Chinese legal name: 丽珠集团丽珠制药厂, 丽珠集团丽珠制药厂Chinese legal name: 丽珠集团丽珠制药厂, 丽珠集团丽珠制药厂Chinese legal name: 丽珠集团丽珠制药厂.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 英卡膦酸二钠片Recorded Chinese product: 英卡膦酸二钠片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 5mg5 mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 丽珠集团丽珠制药厂Chinese legal name: 丽珠集团丽珠制药厂
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20041191
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20041191
Manufacturer
Chinese legal name: 丽珠集团丽珠制药厂 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20041191
生产企业
丽珠集团丽珠制药厂(国产)
适应症
本品为骨代谢改善药，主要用于治疗绝经后骨质疏松症和骨量减少。
用法用量
口服，成人每日早餐前半小时服用5mg(1片)，清水送服。
不良反应
少数患者有腹痛、腹胀、胃不适、倦怠、发热、食欲不振、头痛等，均为轻度，偶有小腿发麻，皮疹，黄疸和肝功能受损等。
禁忌
对本品及其它双膦酸类药物过敏者禁用。
注意事项
1.空腹服药，服药前后半小时，不要进食，清水送服。
2.每晚适量加服钙剂。
3.有严重肾功能受损的患者慎用，定期进行肾功能检查。
4.低钙血症患者慎用，给药后注意血清钙值的变化。
5.有肝功能受损的患者慎用，服用期间定期进行肝功能检查。
贮藏
密闭，防潮。
规格
5mg
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.